Securities code: Changjiangrunfa Health Industry Co.Ltd(002435) securities abbreviation: Changjiangrunfa Health Industry Co.Ltd(002435) Announcement No.: 2022029 Changjiangrunfa Health Industry Co.Ltd(002435)
Announcement of resolutions of the 6th meeting of the 5th board of supervisors
The company and all members of the board of supervisors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
Changjiangrunfa Health Industry Co.Ltd(002435) (hereinafter referred to as “the company”) the sixth meeting of the Fifth Board of supervisors was held in the company’s conference room on April 28, 2022 in combination with communication voting. The general meeting of the board of supervisors was held on February 15, 2024 in the form of written notice of the company. Three supervisors should be present at this meeting and three actually present. The meeting was presided over by Ms. Yu Minfang, chairman of the board of supervisors. The meeting was held in accordance with the relevant provisions of the company law and the articles of association. The following proposals were deliberated and adopted: 1. The proposal on the work report of the board of supervisors in 2021 was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention votes, and agreed to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation;
2、 With 3 affirmative votes, 0 negative votes and 0 abstention votes, the proposal on the company’s 2021 annual financial statement report was deliberated and adopted, and it was agreed to submit it to the company’s 2021 annual general meeting for deliberation;
After review, the board of supervisors believes that the company’s financial report truly, accurately and completely reflects the company’s financial situation and operating results.
3、 With 3 affirmative votes, 0 negative votes and 0 abstention votes, the proposal on the company’s 2021 annual report and its summary was deliberated and adopted, and it was agreed to submit it to the company’s 2021 annual general meeting for deliberation;
In accordance with the provisions of the securities law, the board of supervisors of the company strictly reviewed the 2021 annual report and its summary prepared by the board of directors. All supervisors present at the meeting agreed that the procedures for the preparation and review of Changjiangrunfa Health Industry Co.Ltd(002435) 2021 annual report by the board of directors comply with the laws, administrative laws and regulations and the provisions of the CSRC, and the contents of the report truly, accurately and completely reflect the actual situation of the listed company without any false records Misleading statements or material omissions.
4、 With 3 affirmative votes, 0 negative votes and 0 abstention votes, the proposal on the company’s profit distribution plan in 2021 was deliberated and adopted, and it was agreed to submit it to the company’s 2021 annual general meeting for deliberation;
The proposal and deliberation procedures of the company’s profit distribution plan for 2021 comply with the articles of association and other relevant provisions, match the actual operating performance of the company and the development plan of the company, are conducive to the normal operation and healthy development of the company, have legitimacy, compliance and rationality, and do not harm the interests of investors. Agree to the profit distribution plan and submit it to the general meeting of shareholders for deliberation.
5、 The proposal on the company’s self-evaluation report on internal control in 2021 was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention votes;
After review, the board of supervisors believes that the company can actively improve the corporate governance structure in accordance with the requirements of relevant laws and regulations of China Securities Regulatory Commission and Shenzhen Stock Exchange and in combination with the actual situation of the company. The company’s current internal control system and internal control system meet the requirements of relevant national laws and regulations and the actual needs of the company’s production and operation management, The establishment of the internal control system has played a good role in risk prevention and control in all links of the company’s operation and management. The self-evaluation report of the company’s internal control truly and objectively reflects the construction and operation of the company’s internal control system.
6、 The proposal on the special report on the deposit and use of the company’s raised funds in 2021 was deliberated and adopted by 3 votes in favor, 0 against and 0 abstention;
The board of supervisors verified the deposit and use of the company’s raised funds in 2021 and held that the deposit and use of the company’s raised funds can be carried out in strict accordance with the provisions and requirements of the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange and the management system of raised funds, and the special report on the deposit and use of raised funds in 2021 prepared by the company is true It objectively reflects the use and deposit of the company’s raised funds in 2021.
7、 With 3 affirmative votes, 0 negative votes and 0 abstention votes, the proposal on the provision for asset impairment in 2021 was considered and adopted;
The company’s provision for asset impairment this time is based on the principle of prudence, complies with the relevant provisions of the accounting standards for business enterprises and the company’s accounting policies, can objectively and fairly reflect the company’s operating results and financial status, and is conducive to providing investors with more authentic, reliable and accurate accounting information, without damaging the interests of the company and all shareholders. The decision-making procedure for withdrawing the provision for asset impairment this time complies with the relevant provisions of laws, regulations and the articles of association. Therefore, we agree with the company’s provision for asset impairment.
8、 With 3 affirmative votes, 0 negative votes and 0 abstention votes, the proposal on using some temporarily idle raised funds for cash management was deliberated and approved, and it was agreed to submit it to the 2021 annual general meeting of shareholders of the company for deliberation;
The company’s use of temporarily idle raised funds for cash management is conducive to improving the use efficiency of idle raised funds and cash management income without affecting the effective implementation of raised investment projects. There is no situation of changing the investment direction of raised funds in a disguised manner and damaging the interests of shareholders, which is in line with the interests of the company and all shareholders. We agree that the company will use some temporarily idle raised funds for cash management, and agree to submit them to the general meeting of shareholders for deliberation.
9、 The proposal on the full text and text of the company’s report for the first quarter of 2022 was deliberated and adopted by 3 votes in favor, 0 against and 0 abstention.
After review, the board of supervisors believes that the full text and text of the first quarter report of 2022 prepared and reviewed by the board of directors of the company comply with relevant laws, administrative regulations and the provisions of the CSRC. The company’s report for the first quarter of 2022 is true, accurate and complete without any false records, misleading statements or major omissions. It is hereby announced.
Changjiangrunfa Health Industry Co.Ltd(002435) board of supervisors April 29, 2022
